Advertisement
Advertisement
ASMB
Assembly Biosciences, Inc
31.72
USDSponsored
+0.90
+2.92%
May 13, 16:00 UTC -4
Closed
After-Market
31.75
+0.03
+0.09%
ASMB Earnings Reports
Positive Surprise Ratio
ASMB beat 27 of 39 last estimates.
69%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$8.77M
/-$0.65
Implied change from Q1 26 (Revenue/ EPS)
+6.79%
/+20.37%
Implied change from Q2 25 (Revenue/ EPS)
-8.88%
/-51.13%
Assembly Biosciences, Inc earnings per share and revenue
On May 07, 2026, ASMB reported earnings of -0.54 USD per share (EPS) for Q1 26, beating the estimate of -0.58 USD, resulting in a 7.12% surprise. Revenue reached 8.21 million, compared to an expected 9.45 million, with a -13.10% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.65 USD, with revenue projected to reach 8.77 million USD, implying an increase of 20.37% EPS, and increase of 6.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.12
Surprise
-20.48%
Amphastar Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.71
Actual
$0.42
Surprise
-41.59%
Personalis, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-5.42%
Teva Pharmaceutical Industries Limited - ADR
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.48
Actual
$0.53
Surprise
+8.78%
BridgeBio Pharma, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.84
Surprise
-21.37%
Dr. Reddy's Laboratories Limited - ADR
Report Date
May 12, 2026 For Q4 26
Estimate
$11.40
Actual
$5.73
Surprise
-49.68%
Supernus Pharmaceuticals, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.30
Actual
$0.60
Surprise
+97.69%
Bausch Health Companies Inc
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.69
Actual
$0.78
Surprise
+12.33%
FAQ
What were Assembly Biosciences, Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Assembly Biosciences, Inc reported EPS of -$0.54, beating estimates by 7.12%, and revenue of $8.21M, -13.1% below expectations.
How did the market react to Assembly Biosciences, Inc's Q1 2026 earnings?
The stock price moved down -3.85%, changed from $30.93 before the earnings release to $29.74 the day after.
When is Assembly Biosciences, Inc expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Assembly Biosciences, Inc's next earnings report?
Based on 4
analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.65 and revenue of $8.77M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement